Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
4
×
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
4
×
merck
4
×
national
national blog main
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
bristol-myers squibb
diagnostics
drug prices
immunotherapy
pfizer
president trump
albert bourla
alzheimer's disease
amgen
What
drug
4
×
bio
roundup
new
patients
today
acquisitions
advantages
albert
approval
away
bar
biggest
biogen’s
biopharmaceutical
bourla
bringing
brings
ceo
ceos
companies
company
convo
crispr
dc
earlier
executives
expect
failures
future
gamble
gathered
groups
hearing
held
imports
littered
lower
maker
maps
Language
unknown
unset
Current search:
medicare
×
photo
×
" seattle blog main "
×
drug
×
merck
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away